4
Changes in Ownership
Axogen, Inc. Filed Acc 0001179110-20-012325
VP, Clinical&Translational Sc sold 371 shares at $17.81 ($6,608)
- VP, Clinical&Translational Sc acquired 1,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2020-12-27 | Grant or award | +1,500 | 63,611 | D | ||
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2020-12-29 | Sale | −371 | $17.81 | $6,608 | 63,240 | D |
| Open-market sales · 371 sh · avg $17.81 · $6,608 | |||||||
Loading xslF345X03/edgar.xml…